KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $0.48.

  • Bausch Health Companies' EPS (Weighted Average and Diluted) rose 30869.57% to $0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.97, marking a year-over-year increase of 30638.3%. This contributed to the annual value of -$0.2 for FY2024, which is 8831.53% up from last year.
  • Per Bausch Health Companies' latest filing, its EPS (Weighted Average and Diluted) stood at $0.48 for Q3 2025, which was up 30869.57% from $0.4 recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' EPS (Weighted Average and Diluted) peaked at $1.11 during Q3 2022, and registered a low of -$1.71 during Q1 2021.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.23, with a median of -$0.16 in 2025.
  • As far as peak fluctuations go, Bausch Health Companies' EPS (Weighted Average and Diluted) plummeted by 66500.0% in 2022, and later skyrocketed by 123333.33% in 2025.
  • Bausch Health Companies' EPS (Weighted Average and Diluted) (Quarter) stood at $0.2 in 2021, then plummeted by 665.0% to -$1.13 in 2022, then skyrocketed by 88.6% to -$0.13 in 2023, then skyrocketed by 306.75% to $0.27 in 2024, then surged by 80.24% to $0.48 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.48 in Q3 2025, compared to $0.4 in Q2 2025 and -$0.16 in Q1 2025.